Where Will Zydus Wellness Share Price Be in the Next 3 Years?

The Zydus Wellness share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 596 on 10 July 2026, within a 52 week range of Rs 358 to Rs 607. This article lays out a scenario based Zydus Wellness share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Zydus Wellness Company Overview

Zydus Wellness is a consumer wellness company selling brands such as Complan, Glucon-D, Sugar Free and Nycil across nutrition, health drinks and skin care categories in India. Understanding the business model is the first step in framing any credible Zydus Wellness share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Zydus Wellness
NSE Ticker	ZYDUSWELL
CMP (10 July 2026)	Rs 596
52 Week High	Rs 607
52 Week Low	Rs 358
Market Cap	Rs 18,954 Cr
Stock PE	81.6
Book Value	Rs 183
ROE	4.04%
ROCE	4.96%
Dividend Yield	0.2%

Where Does Zydus Wellness Share Price Stand Today?

The stock trades close to its 52 week high of Rs 607, indicating strong recent momentum. A Zydus Wellness share price forecast built from these levels must assume earnings keep pace with expectations, and the Zydus Wellness share price forecast becomes more sensitive to disappointments, since elevated starting valuations can cap medium term returns.

At the current price, Zydus Wellness commands a market capitalisation of Rs 18,954 Cr and trades at a price to earnings multiple of 81.6. The company generates a return on equity of 4.04% and a return on capital employed of 4.96%, which places it in the category of businesses with a recovering profitability profile. These numbers anchor the Zydus Wellness share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Zydus Wellness Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Zydus Wellness share price forecast between now and 2030, and together they explain most of the dispersion in this Zydus Wellness share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With a recovering profitability profile at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Zydus Wellness share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Consumption Recovery and Rural Demand Tailwinds

FMCG demand is recovering as rural incomes improve, inflation cools and government spending supports consumption. Distribution expansion and premiumisation give branded players such as Zydus Wellness multiple levers to convert category growth into earnings. Sector trends are visible in the Nifty FMCG index, which serves as a useful barometer for the space.

Within the space, investors often benchmark Zydus Wellness against peers such as Dabur India, Marico and Bajaj Consumer Care on growth and valuations before forming a view on the Zydus Wellness share price forecast.

Company Specific Catalysts

The bull case for Zydus Wellness rests on premiumisation of its health and nutrition brands, distribution expansion and new product innovation. If these play out on schedule, the Zydus Wellness share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Zydus Wellness share price forecast, while global risk aversion would do the opposite to the Zydus Wellness share price outlook.

Zydus Wellness Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Zydus Wellness share price forecast using compounded annual growth assumptions applied to the current market price of Rs 596. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year	Bear Case	Base Case	Bull Case	Assumption
2027	Rs 615	Rs 670	Rs 725	2% to 14% CAGR on CMP
2028	Rs 625	Rs 720	Rs 825	2% to 14% CAGR on CMP
2030	Rs 650	Rs 845	Rs 1,070	2% to 14% CAGR on CMP

In the base case scenario of this Zydus Wellness share price forecast, the 2030 level works out to roughly Rs 845, implying steady compounding from today’s levels. The bull case of Rs 1,070 assumes premiumisation of its health and nutrition brands delivers ahead of expectations, while the bear case of Rs 650 captures a scenario where growth stalls. That is an outcome band of about 9 percent to 80 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Zydus Wellness Share Price

The Bull Case

The optimistic Zydus Wellness share price forecast assumes premiumisation of its health and nutrition brands, distribution expansion and new product innovation. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 1,070 by 2030.

The Bear Case

The cautious view centres on the fact that intense competition from larger FMCG players and seasonal demand in categories like Glucon-D affect growth consistency. If these pressures dominate, the Zydus Wellness share price forecast would skew toward the lower band and the stock could stagnate near Rs 650 even by 2030, underperforming broader indices.

Key Risks That Could Change the Zydus Wellness Share Price Outlook

• Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Zydus Wellness share price forecast.
• Valuation risk: At a PE of 81.6, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
• Sector risk: Intense competition from larger FMCG players and seasonal demand in categories like Glucon-D affect growth consistency.
• Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
• Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Zydus Wellness Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Zydus Wellness share price forecast lands in 2030 or what any single Zydus Wellness share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around premiumisation of its health and nutrition brands gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Zydus Wellness share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Zydus Wellness share price live.

Conclusion

The Zydus Wellness share price forecast for the next 3 years spans Rs 650 to Rs 1,070 by 2030 under the scenarios discussed, with a base case near Rs 845. Any credible Zydus Wellness share price forecast must be updated as facts change, and the path will be decided by earnings delivery, premiumisation of its health and nutrition brands and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

What is the Zydus Wellness share price forecast for the next 3 years?

Ans. The Zydus Wellness share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 650 in the bear case to Rs 1,070 in the bull case, with a base case near Rs 845, depending on earnings delivery and market conditions.

What is the Zydus Wellness share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 615 to Rs 725, with a base case around Rs 670. This assumes compounding on the current price of Rs 596 and is illustrative, not a guaranteed outcome.

What is the Zydus Wellness share price forecast for 2028?

Ans. The 2028 scenario range is Rs 625 to Rs 825, with the base case near Rs 720. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Zydus Wellness?

Ans. As of 10 July 2026, Zydus Wellness trades at around Rs 596 on the NSE, within a 52 week range of Rs 358 to Rs 607. Prices change continuously during market hours, so check live quotes before acting.

Is Zydus Wellness a good stock for the long term?

Ans. Zydus Wellness has a credible long term story built on premiumisation of its health and nutrition brands, but it also carries risks since intense competition from larger FMCG players and seasonal demand in categories like Glucon-D affect growth consistency. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Zydus Wellness share price outlook for 2030?

Ans. The Zydus Wellness share price outlook for 2030 spans Rs 650 to Rs 1,070 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Zydus Wellness share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 81.6, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.